Colorectal Cancer Metastasis
📧 Sign up to get email alerts when something new happens for Colorectal Cancer Metastasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status [Phase 2]
A Phase 2 trial evaluating first-line FOLFIRI plus panitumumab in elderly patients with unresectable metastatic colorectal cancer that is RA…
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Sym004 Versus Futuximab or Modotuximab in Patients With mCRC [Phase 2]
A Phase 2 trial comparing Sym004 with Futuximab or Modotuximab in metastatic colorectal cancer was terminated with posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2019-04-11Clinical Trial Update: Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC) [Phase 2]
Phase 2 trial evaluating how BRAF and PIK3K status influences efficacy of FOLFIRI + bevacizumab or cetuximab in RAS wild-type metastatic col…